Literature DB >> 16120185

Effects of administration of oral magnesium on plasma glucose and pathological changes in the aorta and pancreas of diabetic rats.

Nepton Soltani1, Mansoor Keshavarz, Bagher Minaii, Fatemeh Mirershadi, Saleh Zahedi Asl, Ahmad Reza Dehpour.   

Abstract

1. Magnesium deficiency has recently been proposed as a novel factor implicated in the pathogenesis of the complications of diabetes. The purpose of the present study was to determine the relationship between oral Mg supplementation and changes in plasma glucose, calcium, haemoglobin, Ca/Mg ratio, blood pressure and the histology of the pancreas and vascular system in streptozotocin-induced diabetic rats. 2. Ten days after the induction of diabetes in male Wistar rats, half the diabetic animals were divided into six groups, receiving 0, 1, 3, 10, 30 or 50 g/L MgSO4 added into the drinking water for 8 weeks. Plasma glucose and Mg were measured at days 1, 2, 3, 5, 7, 14 and 21 to find the optimum dose of Mg and the time-course of its effect. In addition, histological observations were undertaken. Eight weeks later, all animals were decapitated, the pancreas and thoracic aorta were removed carefully and immersed immediately in 10% formaldehyde for histological study. 3. To evaluate the effects of Mg on plasma glucose, calcium, haemoglobin, Mg and blood pressure, another group of animals was divided into four experimental groups, as follows: (i) non-diabetic controls received tap water for 8 weeks; (ii) acute diabetics received tap water for 10 days; (iii) chronic diabetic controls received tap water for 8 weeks; and (iv) Mg-treated chronic diabetic rats received 10 g/L MgSO4 added into the drinking water 10 days after the induction of diabetes for 8 weeks. 4. Magnesium dose dependently affects plasma glucose levels. The peak effect was reached during the first 24 h following oral administration. Administration of 10 g/L MgSO4 results in the return of normal structure in the diabetic pancreas and aorta. Moreover, this concentration of MgSO4 causes glucose, haemoglobin, calcium, the Ca/Mg ratio and blood pressure to reach normal levels. Although the Mg level increases slightly following the administration of 10 g/L MgSO4 to diabetic rats, it never reaches control levels. 5. On the basis of the results of the present study, it may be concluded that chronic Mg administration may have beneficial effects on diabetes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16120185     DOI: 10.1111/j.0305-1870.2005.04238.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  14 in total

1.  Magnesium Sulfate Improves Some Risk Factors for Atherosclerosis in Patients Suffering from One or Two Coronary Artery Diseases: A Double-blind Clinical Trial Study.

Authors:  Ali Reza Sobhani; Hossein Farshidi; Fariba Azarkish; Mahdiya Eslami; Ebrahim Eftekhar; Mansoor Keshavarz; Nepton Soltani
Journal:  Clin Pharmacol       Date:  2020-09-25

2.  Mg supplementation protects against ritonavir-mediated endothelial oxidative stress and hepatic eNOS downregulation.

Authors:  Xi Chen; I Tong Mak
Journal:  Free Radic Biol Med       Date:  2014-01-14       Impact factor: 7.376

Review 3.  Magnesium in disease prevention and overall health.

Authors:  Stella Lucia Volpe
Journal:  Adv Nutr       Date:  2013-05-01       Impact factor: 8.701

4.  AZT-induced oxidative cardiovascular toxicity: attenuation by Mg-supplementation.

Authors:  I Tong Mak; Joanna J Chmielinska; Jay H Kramer; William B Weglicki
Journal:  Cardiovasc Toxicol       Date:  2009-05-12       Impact factor: 3.231

5.  The role of PPAR-γ and NFKB genes expression in muscle to improve hyperglycemia in STZ-induced diabetic rat following magnesium sulfate administration.

Authors:  Fatemeh Khosravi; Fatemeh Kharazmi; Mitra Kamran; Kianoosh Malekzadeh; Ardeshir Talebi; Nepton Soltani
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2018-06-25

6.  Suppressive effects of natural reduced waters on alloxan-induced apoptosis and type 1 diabetes mellitus.

Authors:  Yuping Li; Takeki Hamasaki; Kiichiro Teruya; Noboru Nakamichi; Zbigniew Gadek; Taichi Kashiwagi; Hanxu Yan; Tomoya Kinjo; Takaaki Komatsu; Yoshitoki Ishii; Sanetaka Shirahata
Journal:  Cytotechnology       Date:  2011-12-06       Impact factor: 2.058

7.  Effect of oral administration of magnesium on Cisplatin-induced nephrotoxicity in normal and streptozocin-induced diabetic rats.

Authors:  Nepton Soltani; Mehdi Nematbakhsh; Fatemeh Eshraghi-Jazi; Ardeshir Talebi; Farzaneh Ashrafi
Journal:  Nephrourol Mon       Date:  2013-08-20

8.  Oral magnesium supplementation in type II diabetic patients.

Authors:  Mehrdad Solati; Elham Ouspid; Saeedeh Hosseini; Nepton Soltani; Mansoor Keshavarz; Mohsen Dehghani
Journal:  Med J Islam Repub Iran       Date:  2014-07-15

9.  Effects of Brown Seaweed (Sargassum polycystum) Extracts on Kidney, Liver, and Pancreas of Type 2 Diabetic Rat Model.

Authors:  Mahsa Motshakeri; Mahdi Ebrahimi; Yong Meng Goh; Hemn Hassan Othman; Mohd Hair-Bejo; Suhaila Mohamed
Journal:  Evid Based Complement Alternat Med       Date:  2014-01-08       Impact factor: 2.629

10.  Protective effect of magnesium on renal function in STZ-induced diabetic rats.

Authors:  Mohammad Reza Parvizi; Mohsen Parviz; Seyed Mohammad Tavangar; Nepton Soltani; Mehri Kadkhodaee; Behjat Seifi; Yaser Azizi; Mansoor Keshavarz
Journal:  J Diabetes Metab Disord       Date:  2014-08-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.